VN8

4.88%

4.3¢ vonex limited..

Ann: December Quarterly Update & Appendix 4C, page-8

First 8 Last

Share
Profile

Follow
Bumpken

308 Posts.

75

02/02/22

13:22

Post #: 59300643
Share

Originally posted by LD99: ↑

Land and expand is great while the price of debt is cheap, when interest rates start moving up I think the market is waiting for some cost synergies and cross selling opportunities to outline themselves before getting in.

At that point I wouldn't be surprised if we were sitting at an ARR of 3-4 or a PE of 15-20 upwards of a market cap of $100mill in FY23+.

I don't understand your statement "earnings of $8mill per quarter" I think you mean to say revenue. Margins are definitely quality in the SME space and much larger than many telcomms going forward.

The importance of reliable and secure business interconnectivity has become even more prominent in a pandemic-impacted world, and so enterprises are placing greater priority on possessing and maintaining quality communication networks.

A risk that I can outline is just because the acquisition should benefit VN8 in the long-run doesn’t mean the market will enjoy the short term pain to the VN8 cash balance and shareholder dilution. Acquisitive strategies in no way guarantee that a larger telco will look to acquire VN8 in the end, particularly if user growth slows.

I think the market is waiting for the EBITDA results from the half yearly and the accounts to make their final investment decisions. We still haven't seen a full year with MNF Direct under VN8 yet so we look forward to continued progress here.

I'd think by mid-2022, both acquisitions should be fully integrated into VN8, and so the full impact on ARR, PBX customers and EBITDA will flow through to the financial reports.

Expand

Yes sorry I meant revenue, whoops.

All very logical and valid points for me to be aware of, cheers.

Seems as though our general outlook is very similar for the next 12 months

VN8 Price at posting: 10.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

First 8 Last

Add VN8 (ASX) to my watchlist

(20min delay)
Last 4.3¢		Change 0.002(4.88%)		Mkt cap ! $15.55M

Open	High	Low	Value	Volume
4.2¢	4.3¢	4.2¢	$427.8K	10.18M

Buyers (Bids)

No.	Vol.	Price($)
4	1563810	4.2¢

Sellers (Offers)

Price($)	Vol.	No.
4.3¢	18118	1

View Market Depth

No.	Vol.	Price($)
2	63810	0.042
3	1683411	0.041
1	25000	0.040
2	25664	0.039
1	263159	0.038

Price($)	Vol.	No.
0.044	235909	2
0.045	2000000	1
0.046	182535	2
0.050	50000	1
0.053	16540	1

Last trade - 15.59pm 04/10/2024 (20 minute delay)

VN8 (ASX) Chart

Ann: December Quarterly Update & Appendix 4C, page-8

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: December Quarterly Update & Appendix 4C, page-8

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News